These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22363554)

  • 41. Sulcal morphology as cognitive decline predictor in older adults with memory complaints.
    Mortamais M; Gutierrez LA; Balem M; Bars EL; de Champfleur NM; Bouyahia A; Chupin M; Perus L; Fisher C; Vellas B; Andrieu S; Mangin JF; Berr C; Gabelle A;
    Neurobiol Aging; 2022 May; 113():84-94. PubMed ID: 35325814
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sulcal morphology in Alzheimer's disease: an effective marker of diagnosis and cognition.
    Bertoux M; Lagarde J; Corlier F; Hamelin L; Mangin JF; Colliot O; Chupin M; Braskie MN; Thompson PM; Bottlaender M; Sarazin M
    Neurobiol Aging; 2019 Dec; 84():41-49. PubMed ID: 31491594
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complexity analysis of cortical surface detects changes in future Alzheimer's disease converters.
    Ruiz de Miras J; Costumero V; Belloch V; Escudero J; Ávila C; Sepulcre J
    Hum Brain Mapp; 2017 Dec; 38(12):5905-5918. PubMed ID: 28856799
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Longitudinal assessment of neuroimaging and clinical markers in autosomal dominant Alzheimer's disease: a prospective cohort study.
    Yau WW; Tudorascu DL; McDade EM; Ikonomovic S; James JA; Minhas D; Mowrey W; Sheu LK; Snitz BE; Weissfeld L; Gianaros PJ; Aizenstein HJ; Price JC; Mathis CA; Lopez OL; Klunk WE
    Lancet Neurol; 2015 Aug; 14(8):804-813. PubMed ID: 26139022
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Neuropsychological Correlates of Brain Perfusion and Gray Matter Volume in Alzheimer's Disease.
    Tai H; Hirano S; Sakurai T; Nakano Y; Ishikawa A; Kojima K; Li H; Shimada H; Kashiwado K; Mukai H; Horikoshi T; Sugiyama A; Uno T; Kuwabara S
    J Alzheimers Dis; 2020; 78(4):1639-1652. PubMed ID: 33185599
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improved prediction of Alzheimer's disease with longitudinal white matter/gray matter contrast changes.
    Grydeland H; Westlye LT; Walhovd KB; Fjell AM
    Hum Brain Mapp; 2013 Nov; 34(11):2775-85. PubMed ID: 22674625
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mini-mental state examination is sensitive to brain atrophy in Alzheimer's disease.
    Fjell AM; Amlien IK; Westlye LT; Walhovd KB
    Dement Geriatr Cogn Disord; 2009; 28(3):252-8. PubMed ID: 19786777
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Conventional MRI volumetric measures of parietal and insular cortex in Alzheimer's disease.
    Foundas AL; Eure KF; Seltzer B
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 Oct; 20(7):1131-44. PubMed ID: 8938815
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Malignant progression in parietal-dominant atrophy subtype of Alzheimer's disease occurs independent of onset age.
    Na HK; Kang DR; Kim S; Seo SW; Heilman KM; Noh Y; Na DL
    Neurobiol Aging; 2016 Nov; 47():149-156. PubMed ID: 27592283
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A neuroradiological study on the influence of cerebral atrophy and white matter lesion on cognitive function in the elderly].
    Terai S
    Nihon Ronen Igakkai Zasshi; 2004 Sep; 41(5):521-7. PubMed ID: 15515734
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structural MRI biomarkers for preclinical and mild Alzheimer's disease.
    Fennema-Notestine C; Hagler DJ; McEvoy LK; Fleisher AS; Wu EH; Karow DS; Dale AM;
    Hum Brain Mapp; 2009 Oct; 30(10):3238-53. PubMed ID: 19277975
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical presentation of Moroccan cases with Alzheimer's disease].
    El Kadmiri N; Zaid Y; Hamzi K; Nadifi S; Slassi I; El Moutawakil B
    Encephale; 2014 Dec; 40(6):481-6. PubMed ID: 25127896
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Volumetric study of lobar atrophy in Pick complex and Alzheimer's disease.
    Fukui T; Kertesz A
    J Neurol Sci; 2000 Mar; 174(2):111-21. PubMed ID: 10727696
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
    Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
    Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Microanatomical correlates of cognitive ability and decline: normal ageing, MCI, and Alzheimer's disease.
    Chance SA; Clover L; Cousijn H; Currah L; Pettingill R; Esiri MM
    Cereb Cortex; 2011 Aug; 21(8):1870-8. PubMed ID: 21239393
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
    Yew B; Nation DA;
    Brain; 2017 Jul; 140(7):1987-2001. PubMed ID: 28575149
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cognitive impairment and diffuse white matter atrophy in alcoholics.
    Mochizuki H; Masaki T; Matsushita S; Ugawa Y; Kamakura K; Arai H; Motoyoshi K; Higuchi S
    Clin Neurophysiol; 2005 Jan; 116(1):223-8. PubMed ID: 15589200
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Altered amplitude of low-frequency fluctuations in early and late mild cognitive impairment and Alzheimer's disease.
    Liang P; Xiang J; Liang H; Qi Z; Li K; Alzheimer's Disease NeuroImaging Initiative
    Curr Alzheimer Res; 2014 May; 11(4):389-98. PubMed ID: 24720892
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantification of sulcal emergence timing and its variability in early fetal life: Hemispheric asymmetry and sex difference.
    Yun HJ; Lee HJ; Lee JY; Tarui T; Rollins CK; Ortinau CM; Feldman HA; Grant PE; Im K
    Neuroimage; 2022 Nov; 263():119629. PubMed ID: 36115591
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matter.
    DeCarli C; Grady CL; Clark CM; Katz DA; Brady DR; Murphy DG; Haxby JV; Salerno JA; Gillette JA; Gonzalez-Aviles A; Rapoport SI
    J Neurol Neurosurg Psychiatry; 1996 Feb; 60(2):158-67. PubMed ID: 8708645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.